Projects

We seek to formulate a herbal remedy to treat tooth decay and prevent unnecessary tooth extraction. This will save our poor communities the costs of tooth extractions and the complications that come along with it.

The aim of this project is to formulate and preclinically evaluate the efficacy and safety of a herbal product, PRIVIRID containing Latency Reversing Agents from indigenous medicinal plants in Eastern Uganda.

Cassava is a renewable and abundant crop that requires relatively low inputs compared to other crops. BPL produced from cassava has lower carbon emissions compared to fossil fuels, contributing to the reduction of greenhouse gas emissions.

We propose to formulate and develop natural product-based spray/powder for Inhibition of aflatoxin synthesis by A. flavus from EO and Trichoderma spp either in singular or in combination.

The aim of this project is to develop scientifically validated and standardized antidiabetic phytomedicines from identified priority Ugandan medicinal plants.

Research is conducted from selected medicinal plants with potential application in health and improved crop production. It is ongoing project.

In this study, the anticancer potential of natural products from four plant species was investigated. The use of nanoparticle drug delivery systems to enhance anticancer activity of β-sitosterol as a model natural products was also investigated.

The research was done by evaluating the toxicity of the Eucalyptus globulus Leaf extracts in animal models.

The project was to evaluate three medicinal plants of fabaceae family with biodiversity against mycobacterium tuberculosis.

Evaluation of the anti-SARS-CoV-2 activity of three selected Ugandan medicinal plants and formulation of herbal product (s) for management of COVID -19 (2020-2021). This project is funded by the government of Uganda through the Ministry of Science, Techno